Showing 1 - 9 results of 9 for search 'Hirofumi Hamano', query time: 0.05s Refine Results
  1. 1
    Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database

    Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database by Yusuke Igawa, Yusuke Igawa, Hirofumi Hamano, Hirofumi Hamano, Satoru Esumi, Tatsuaki Takeda, Makoto Kajizono, Ryo Kikuoka, Ikuya Kimura, Yoshito Zamami, Yoshito Zamami

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects

    Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects by Hideki Nawa, Hirofumi Hamano, Takahiro Niimura, Koji Miyata, Kenta Yagi, Mitsuhiro Goda, Yoshito Zamami, Keisuke Ishizawa

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Evaluation of Potential Complications of Interstitial Lung Disease Associated With Antiandrogens Using Data From Databases Reporting Spontaneous Adverse Effects

    Evaluation of Potential Complications of Interstitial Lung Disease Associated With Antiandrogens Using Data From Databases Reporting Spontaneous Adverse Effects by Hideki Nawa, Takahiro Niimura, Hirofumi Hamano, Kenta Yagi, Mitsuhiro Goda, Yoshito Zamami, Yoshito Zamami, Keisuke Ishizawa, Keisuke Ishizawa

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination

    Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination by Takahiro Niimura, Takahiro Niimura, Mitsuhiro Goda, Mitsuhiro Goda, Koji Miyata, Jun Matsumoto, Toshihiko Yoshioka, Toshihiko Yoshioka, Hirofumi Hamano, Hirofumi Hamano, Fuka Aizawa, Fuka Aizawa, Kenta Yagi, Kenta Yagi, Yuki Izawa-Ishizawa, Yuki Izawa-Ishizawa, Yoshito Zamami, Yoshito Zamami, Keisuke Ishizawa, Keisuke Ishizawa, Keisuke Ishizawa

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Drug-Repositioning Approaches Based on Medical and Life Science Databases

    Drug-Repositioning Approaches Based on Medical and Life Science Databases by Yoshito Zamami, Yoshito Zamami, Yoshito Zamami, Hirofumi Hamano, Takahiro Niimura, Fuka Aizawa, Kenta Yagi, Mitsuhiro Goda, Yuki Izawa-Ishizawa, Keisuke Ishizawa, Keisuke Ishizawa

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Assessing the effects of interprofessional education by hospital pharmacists on pharmaceutical students using a self-evaluation scale

    Assessing the effects of interprofessional education by hospital pharmacists on pharmaceutical students using a self-evaluation scale by Fuka Aizawa, Hirofumi Hamano, Naoto Okada, Kenta Yagi, Mitsuhiro Goda, Hideki Nawa, Yuya Horinouchi, Toshimi Nakamura, Harumasa Hakuno, Kazuaki Shinomiya, Yoshito Zamami, Masahiko Azuma, Masashi Akaike, Keisuke Ishizawa

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage

    Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage by Toshihiko Yoshioka, Mitsuhiro Goda, Masaya Kanda, Sayuri Itobayashi, Yugo Sugimoto, Yuki Izawa‐Ishizawa, Kenta Yagi, Fuka Aizawa, Koji Miyata, Takahiro Niimura, Hirofumi Hamano, Takumi Sakurada, Yoshito Zamami, Keisuke Ishizawa

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Effects of 5‐HT₃ receptor antagonists on cisplatin‐induced kidney injury

    Effects of 5‐HT₃ receptor antagonists on cisplatin‐induced kidney injury by Mitsuhiro Goda, Masaya Kanda, Toshihiko Yoshioka, Ami Yoshida, Yoichi Murai, Yoshito Zamami, Fuka Aizawa, Takahiro Niimura, Hirofumi Hamano, Naoto Okada, Kenta Yagi, Masayuki Chuma, Yuki Izawa‐Ishizawa, Keisuke Ishizawa

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis

    Discovery of preventive drugs for cisplatin‐induced acute kidney injury using big data analysis by Masaya Kanda, Mitsuhiro Goda, Akiko Maegawa, Toshihiko Yoshioka, Ami Yoshida, Koji Miyata, Fuka Aizawa, Takahiro Niimura, Hirofumi Hamano, Naoto Okada, Takumi Sakurada, Masayuki Chuma, Kenta Yagi, Yuki Izawa‐Ishizawa, Hiroaki Yanagawa, Yoshito Zamami, Keisuke Ishizawa

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: